Zurich: Good results, attractive share price
The insurance company presents good key figures for the first half of the year. In particular, the profitable commercial non-life business is performing well, and operating profitability in this segment remains high. The company continues to be very well positioned, ZKB's Equity Research rates the share as "overweight", and the P/E ratio of 14 also indicates a favorable valuation.
Swiss Life: Above expectations
Although the individual business units of the group reported different key figures for the first half of the year, the profit at group level still exceeded analysts' expectations. The majority of these analysts continue to recommend the share to buy, and ZKB Equity Research also rates it as "overweight". Higher interest rates, which are beneficial for the Zurich-based insurance company overall, are contributing to this.
Swiss Re: Improvements
Swiss Re, Switzerland's largest reinsurance company, also reported good profit figures for the first half of the year. Optimizations in the non-life insurance sector have made a significant contribution; price increases and business restructuring support the company's earnings ar. ZKB Equity Research rates the share as "market weight".
BRC on Zurich, Swiss Life and Swiss Re
Insurance stocks from Europe and the USA can also be used to optimize returns. European insurance stocks in particular are often less volatile than stocks from other sectors, but still yield attractive coupons.
ZKB Outperformance-Zertifikat Nestlé SA Namenaktie 149280911 / CH1492809111 |
ZKB Bonus-Outperformance-Zertifikat Last Look auf einen Basket Barry Callebaut N/Nestlé N 140252016 / CH1402520162 |
0.31% (0.25% p.a.) ZKB Barrier Reverse Convertible Last Look on worst of mit Partizipation Barry Cal... 144652684 / CH1446526845 |
8.60% p.a. ZKB Callable Barrier Reverse Convertible, 09.03.2026 on worst of BMW GY/CLN SE/SIE GY Bay... 135805173 / CH1358051733 |
ZKB Discount-Zertifikat Nestlé SA Namenaktie 121826861 / CH1218268618 |